Coming soon: epiOpioid, our innovative test targeting the OPRM1 receptor's methylation patterns to assess your genetic predisposition to opioid addiction, offering a new dimension in personalized addiction management and prevention
Under Development
No instructions available.
We support 24 hours a day
You have 30 days to return
100% Secure & Safe
MTL Epitherapeutics
600 – 2000 AV McGill College Montreal, QC CA H3A3H3
+1 (514) 448 2185
EpiMedTechGlobal (EMTG)
60 Paya Lebar Road,
#08-06 Paya Lebar Square
Singapore 409051
US Epitherapeutics
1829 Reisterstown Rd, Suite: 350 Baltimore, MD 21208
+1 (347) 216 0654
HKG epiTherapeutics
Unit 313-315, 3/F Biotech Centre 2
11 Science Park West Avenue
Hong Kong Science Park
Shatin, N.T., Hong Kong
Founded in 2016 by Prof. Moshe Szyf, a global pioneer in the dynamic and rapidly evolving field of epigenetics, EpiMedTech Global (EMTG) stands as a force driving innovation. Headquartered in Singapore, EMTG operates a research and diagnostic lab at the Hong Kong Science Park, which serves as the epicenter of groundbreaking endeavors. Additionally, our innovation and bioinformatics arm, MTL Epitherapeutics, is based in Montreal, Canada. Our dedicated scientists are committed to advancing epigenetics and early disease detection. At EMTG, it’s not just about detecting diseases; it’s about offering solutions that promote longevity through the hidden stories in our DNA.
©2023, MTL Epitherapeutics. All Rights Reserved.
Reviews
There are no reviews yet.